Myriad Goes Direct (Again)

Myriad Genetic Laboratories develops and markets proprietary predictive and personalized medicine products. This includes the poorly branded BRACAnalysis, to assess […]

Read more »

South Korean FDA Approves Cynosure’s Accolade Workstation for Pigmented Lesions

Although freckles occur most often in light skinned individuals with blond hair and blue eyes, freckles are also common among […]

Read more »

BioElectronics Corp. Merits a First Look

Most investors won’t touch a stock trading on the pink sheets with a ten foot medical device. But for the […]

Read more »

[Video Profile] Interview with Ralph Makar, President & CEO of Bioject Medical

Bioject Medical develops and markets needle-free injection technology used to administer injectable medications. Bioject’s technology works by forcing liquid medication […]

Read more »

Bad News for Blood Substitutes

Blood substitutes don’t require refrigeration or cross-matching, have a long shelf life, and reduce the risk of iatrogenic infection. They […]

Read more »

CryoLife on Firm Footing: EPS Increases, Revenues Up, Raises Guidance

Revenues at CryoLife rose 4% to $25.6 million in the first quarter of 2008. Net income was $2.8 million, or […]

Read more »